Consumer Confidential: Always look on the bright side of life, says CEO who raised EpiPen price by more than 400 percent
The myriad problems with the U.S. healthcare system aren't the fault of any one person. But every so often, an industry executive spouts something so wrong-headed, it shines a helpful light on what we're up against.
Heather Bresch, chief executive of the drug company Mylan, maker of EpiPens, stepped into it Monday in a CNN podcast.
After about 40 minutes of benign, getting-to-know-you questions, interviewer Poppy Harlow finally got around to asking about the lingering stink that surrounds Bresch having jacked up the price of life-saving EpiPens by more than 400 percent.
